We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.66%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$89.3B
AUM Growth
+$8.23B
(+10%)
Cap. Flow
+$1.9B
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
24.87%
Holding
4,460
New
1,490
Increased
1,679
Reduced
1,235
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$60.1M |
| 2 |
TSMC
TSM
|
+$59.1M |
| 3 |
Tesla
TSLA
|
+$56M |
| 4 |
Apple
AAPL
|
+$55.2M |
| 5 |
Amazon
AMZN
|
+$47.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$102M |
| 2 |
Everest Group
EG
|
+$27.4M |
| 3 |
Chevron
CVX
|
+$25M |
| 4 |
Wells Fargo
WFC
|
+$24.9M |
| 5 |
Crane NXT
CXT
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.27% |
| 2 | Healthcare | 12.98% |
| 3 | Financials | 12.17% |
| 4 | Consumer Discretionary | 11.18% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Amylyx Pharmaceuticals
AMLX
$2.54B
| $1.47M | ﹤0.01% |
68,095
-7,867
| -10% | -$212K |
|
|
FSR
2077
DELISTED
Fisker Inc.
FSR
| $1.47M | ﹤0.01% |
260,391
-14,453
| -5% | -$83.3K |
|
2078
Zeta Global
ZETA
$6.69B
| $1.47M | ﹤0.01% |
171,750
+41,487
| +32% | +$379K |
|
2079
Dell
DELL
$293B
| $1.46M | ﹤0.01% |
27,029
-254,579
| -90% | -$11.7M |
|
2080
1st Source
SRCE
$2.12B
| $1.45M | ﹤0.01% |
34,639
+119
| +0.3% | +$5.12K |
|
2081
Quanterix
QTRX
$190M
| $1.44M | ﹤0.01% |
63,836
-2,640
| -4% | -$47.1K |
|
2082
GrafTech
EAF
$212M
| $1.44M | ﹤0.01% |
28,517
+2,496
| +10% | +$116K |
|
2083
Vipshop
VIPS
$7.53B
| $1.44M | ﹤0.01% |
+87,043
| New | +$1.36M |
|
2084
SI-BONE Inc
SIBN
$834M
| $1.43M | ﹤0.01% |
53,070
+1,934
| +4% | +$47.2K |
|
2085
ADT
ADT
$5.58B
| $1.43M | ﹤0.01% |
237,122
+19,801
| +9% | +$124K |
|
|
AAN
2086
DELISTED
The Aaron's Company Inc
AAN
| $1.43M | ﹤0.01% |
101,106
-2,384
| -2% | -$29.5K |
|
2087
Pliant Therapeutics
PLRX
$65M
| $1.43M | ﹤0.01% |
+78,842
| New | +$1.87M |
|
2088
FIGS
FIGS
$2.37B
| $1.43M | ﹤0.01% |
172,725
+5,139
| +3% | +$39.1K |
|
2089
Teekay Tankers
TNK
$2.68B
| $1.42M | ﹤0.01% |
37,266
+1,326
| +4% | +$51.6K |
|
2090
Hanmi Financial
HAFC
$946M
| $1.42M | ﹤0.01% |
95,242
-895
| -0.9% | -$14.3K |
|
2091
nLIGHT
LASR
$3.17B
| $1.42M | ﹤0.01% |
92,199
+21,922
| +31% | +$268K |
|
2092
Stem
STEM
$52.7M
| $1.42M | ﹤0.01% |
12,414
+2,013
| +19% | +$200K |
|
|
LGF.B
2093
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $1.42M | ﹤0.01% |
169,893
-16,543
| -9% | -$163K |
|
|
TSE
2094
DELISTED
Trinseo
TSE
| $1.42M | ﹤0.01% |
111,828
-3,291
| -3% | -$53.2K |
|
2095
Viridian Therapeutics
VRDN
$2.67B
| $1.42M | ﹤0.01% |
59,482
+6,514
| +12% | +$167K |
|
2096
Central Pacific Financial
CPF
$1B
| $1.41M | ﹤0.01% |
89,961
-13,186
| -13% | -$208K |
|
2097
PAR Technology
PAR
$735M
| $1.41M | ﹤0.01% |
42,878
+2,321
| +6% | +$77.6K |
|
2098
Lennar Class B
LEN.B
$20.8B
| $1.41M | ﹤0.01% |
13,128
-584
| -4% | -$54.8K |
|
2099
Opko Health
OPK
$1.02B
| $1.41M | ﹤0.01% |
648,704
-13,959
| -2% | -$21.8K |
|
2100
Select Water Solutions
WTTR
$2.61B
| $1.41M | ﹤0.01% |
173,686
+50,877
| +41% | +$385K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2023 Portfolio in Review
As of Q2 2023, RhumbLine Advisers held 4,460 positions worth $89.3B, up 10% from $81B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
RhumbLine Advisers's Q2 2023 filing shows 1,490 new, 1,679 increased, 1,235 reduced and 38 closed positions. Its largest new stake was TSMC: 635,517 shares worth $64.1M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q2 2023 buy was TSMC: 635,517 shares worth $64.1M.
- RhumbLine Advisers added most to Microsoft in Q2 2023, an estimated $60.1M increase.
- RhumbLine Advisers's biggest Q2 2023 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $102M.
- RhumbLine Advisers fully exited Everest Group in Q2 2023, selling an estimated $27.4M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $89.3B portfolio in Q2 2023.
- RhumbLine Advisers opened 1,490 new positions and closed 38 in Q2 2023.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $89.3B.
Based on RhumbLine Advisers's 13F filing for Q2 2023, filed 8 Aug 2023.